AlphAIAlphAI — Financial news for AI agents
finance.biggo.comNOV 33 min read$CBOE

Stock Perpetual Futures as Cboe, Citadel Securities Back Challenge — BigGo Finance

Capital Markets Alliance, backed by Cboe (CBOE), Citadel Securities, and others, sued the CFTC to overturn its approval of stock perpetual futures, arguing they are securities-based swaps under SEC authority. The CFTC claims the policy extends perpetual futures to traditional securities. Cboe shares fell 0.90% on the news.

Original reporting
finance.biggo.com
Published Nov 3, 2026, 10:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Stock Perpetual Futures as Cboe, Citadel Securities Back Challenge — BigGo Finance — source image
Source · finance.biggo.com
Decision brief

The 30-second read

$CBOEBearishLow
01

Why it matters

Regulatory outcome will shape the future of perpetual futures on equities, affecting market‑structure participants and potentially altering the competitive landscape for exchange‑offered derivatives.

02

Market read

The suit introduces regulatory risk for exchange‑listed perpetual futures, with immediate price impact on CBOE and broader implications for the derivatives market.

03

What to watch

The lawsuit may prompt the SEC to clarify its jurisdiction, which could open alternative pathways for similar products.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

The Capital Markets Alliance, comprising CBOE, Citadel Securities and the Healthy Markets Association, filed a lawsuit to overturn the CFTC's approval of stock perpetual futures, arguing they are securities‑based swaps under SEC authority.

Company-level read

Ticker impact

$CBOEBearishHigh confidence
Context

CBOE shares fell 0.90% after the lawsuit was announced, reflecting market reaction to the regulatory challenge.

Expected impact

likely downside pressure as investors assess potential loss of new product revenue

Evidence & confidence

CBOE is a named plaintiff and its share price moved immediately on the news; the outcome could affect its ability to launch new products.

Market effects

Sector

Potentially limits the rollout of stock perpetual futures, affecting exchanges and broker‑dealers that could have offered the products.

Regional

U.S. equity markets may see modest volatility in exchange‑related stocks.

Global

Sets a precedent for how U.S. regulators treat securities‑based swaps, influencing global market‑structure discussions.

Counterpoint

What could challenge this read

If the CFTC policy is upheld, CBOE could gain a first‑mover advantage in a new product class.

Key entities

  • Industry Group
    Capital Markets Alliance

    Newly formed alliance of exchanges and broker‑dealers challenging CFTC policy.

  • Regulator
    CFTC

    U.S. Commodity Futures Trading Commission that approved the perpetual futures contracts.

Read at source← All news

Also covered by

4 outlets

Related articles

NOV 4
$CBOEMed

CFTC Perpetual Futures on Stocks Hit by Cboe-Backed Lawsuit

CFTC approved perpetual futures tied to individual stocks for trading on US exchanges. Chairman Michael Selig stated the contracts are approved under Commission Regulation 40.3. The Capital Markets Alliance, including Cboe, Citadel Securities, and others, filed a lawsuit challenging the approval, arguing the contracts fall under SEC jurisdiction and alleging procedural violations. Cboe's CEO Craig Donohue stated the approvals threaten investor protection and market integrity.

coingabbar.com2 min
NOV 4
$CBOEMed

Cboe and Citadel Sue to Stop US Stock Perps Hours After the CFTC Approved Them: Why Hyperliquid’s $5 Billion-a-Day Market Has the Most at Stake

Cboe and Citadel Securities sued the CFTC to block stock perpetual futures, hours after the regulator approved them. The lawsuit aims to prevent US exchanges from offering these products, which are popular on Hyperliquid's platform. Hyperliquid's HYPE token saw volatility but remains up 2.8% in 24 hours. The outcome could impact Hyperliquid's US market expansion and competitors like Coinbase and Kalshi.

finance.yahoo.com3 min
NOV 4
$CBOEMed

Cboe Joins CMA Lawsuit Seeking to Overturn CFTC Stock Perpetual Approval

Cboe joined the Capital Markets Alliance (CMA) in suing to overturn the CFTC's approval of single-stock perpetual contracts. The case seeks to classify these derivatives as security-based swaps and block the approval. The CFTC allowed trading to begin on Nov. 3, while Cboe's CEO argues they should be regulated under U.S. securities laws. The case involves Coinbase, Kalshi, and Bitnomial.

tokenpost.com4 min
NOV 3
$CBOEMed

Cboe Seeks Injunction Against CFTC Approval of Equity Perpetuals

Cboe Global Markets (C67.DE) joined a legal action against the CFTC's approval of perpetual derivatives on U.S. stocks and ETFs, seeking injunctive relief. Cboe argues these products should be traded on registered securities platforms with investor protections. CFTC Chairman Michael S. Selig supports the approval for risk management and price discovery. The dispute centers on whether these contracts are security futures or swaps, with Cboe favoring SEC jurisdiction.

securities.io6 min
NOV 2
$CBOEMed

Keefe Bruyette raises CBOE Holdings stock price target on derivatives strength

Keefe Bruyette & Woods raised CBOE Holdings' (NYSE:CBOE) price target to $350 from $320, citing strong performance in derivatives and data segments. The company reported 14% revenue growth and a 54% gross profit margin. CBOE also surpassed Q3 2026 earnings expectations with $3.63 EPS and $712.2M revenue, up 18% year-over-year. Wells Fargo also increased its price target to $357.

investing.com2 min